Alex J. Szubert

First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial

Gareth J. Morgan, Faith E. Davies, Walter M. Gregory et al. · The Lancet · 2010 · 566 citations · Full text

Hematological Malignancy, Zoledronic Acid, Oncology +8

Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa

James Hakim, Victor Musiime, Alex J. Szubert et al. · New England Journal of Medicine · 2017 · 213 citations · Full text

Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial

Gareth J. Morgan, J. Anthony Child, Walter M. Gregory et al. · The Lancet Oncology · 2011 · 161 citations · Full text

Effects of induction and maintenance plus long-term bisphosphonates on bone disease in patients with multiple myeloma: the Medical Research Council Myeloma IX Trial

Gareth J. Morgan, Faith E. Davies, Walter M. Gregory et al. · Blood · 2012 · 130 citations · Full text

Gender Disparities in the Tumor Genetics and Clinical Outcome of Multiple Myeloma

Kevin Boyd, Fiona M. Ross, Laura Chiecchio et al. · Cancer Epidemiology Biomarkers & Prevention · 2011 · 56 citations · Full text